Safety of select headache medications in patients with cerebral and spinal cavernous malformations
Background: Patients with cerebral or spinal cavernous malformations (CM) and a primary headache disorder are often limited in medication options due to concern for bleeding risk. Methods: From a prospective cohort of CM patients (2015–2020), demographics, mode of clinical presentation, and radiogra...
Guardado en:
Autores principales: | Kelly D Flemming, Chia-Chun Chiang, Robert D Brown, Giuseppe Lanzino |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b21a73610f424736881bbc0f1d1940ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endothelial cell clonal expansion in the development of cerebral cavernous malformations
por: Matteo Malinverno, et al.
Publicado: (2019) -
A novel insight into differential expression profiles of sporadic cerebral cavernous malformation patients with different symptoms
por: Hilal Eren Gozel, et al.
Publicado: (2021) -
Successful resection of the recurrence of a cavernous malformation of the optic chiasm
por: Martin Scholz, et al.
Publicado: (2008) -
Assessing the association of common genetic variants in EPHB4 and RASA1 with phenotype severity in familial cerebral cavernous malformation
por: Foram Choksi, et al.
Publicado: (2021) -
Remarkable Clinical Improvement Following Microsurgical Resection of Left Lingual Gyrus Cerebral Cavernous Malformation: A Case Report
por: Samer S. Hoz, et al.
Publicado: (2021)